Abstract
The beta (β)-cell mass formed during embryogenesis is amplified by cell replication during fetal and early postnatal development. Thereafter, β cells become functionally mature, and their mass is maintained by a low rate of replication. For those few β cells that replicate in adult life, it is not known how replication is initiated nor whether this occurs in a specialized subset of β cells. We capitalized on a YAP overexpression system to induce replication of stem-cell-derived β cells and, by single-cell RNA sequencing, identified an upregulation of the leukemia inhibitory factor (LIF) pathway. Activation of the LIF pathway induces replication of human β cells in vitro and in vivo. The expression of the LIF receptor is restricted to a subset of transcriptionally distinct human β cells with increased proliferative capacity. This study delineates novel genetic networks that control the replication of LIF-responsive, replication-competent human β cells.
Original language | English (US) |
---|---|
Pages (from-to) | 327-338.e6 |
Journal | Cell Metabolism |
Volume | 31 |
Issue number | 2 |
DOIs | |
State | Published - Feb 4 2020 |
Keywords
- CEBPD
- LIF
- STAT3
- beta cells
- beta-cell regeneration
- beta-cell replication
- diabetes
- single cell
ASJC Scopus subject areas
- Physiology
- Molecular Biology
- Cell Biology